124 related articles for article (PubMed ID: 60190)
1. The contribution of plasma protease inhibitors to antiplasmin activity in man.
Crawford GP; Ogston D; Douglas AS
Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
[TBL] [Abstract][Full Text] [Related]
2. The measurement of human plasma antiplasmin activity by radial diffusion assay.
Andes WA
Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
[TBL] [Abstract][Full Text] [Related]
3. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
Collen D
Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.
Chan JY; Burrowes CE; Habal FM; Movat HZ
Biochem Biophys Res Commun; 1977 Jan; 74(1):150-8. PubMed ID: 65173
[No Abstract] [Full Text] [Related]
6. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
de Vonne TL; Mouray H
Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
[TBL] [Abstract][Full Text] [Related]
7. Plasmin inactivation in plasma.
Haselager EM; Goote TM; Vreeken J
Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
[TBL] [Abstract][Full Text] [Related]
8. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
Edy J; Collen D
Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
[TBL] [Abstract][Full Text] [Related]
9. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
Zhabin SG; Zorin NA; Musatov MI
Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
[TBL] [Abstract][Full Text] [Related]
10. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.
Teger-Nilsson AC; Friberger P; Gyzander E
Scand J Clin Lab Invest; 1977 Sep; 37(5):403-9. PubMed ID: 73215
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the inhibition of thrombin by three plasma protease inhibitors.
Downing MR; Bloom JW; Mann KG
Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421
[TBL] [Abstract][Full Text] [Related]
12. Blood inhibitory capacity toward exogenous plasmin.
Banbula A; Zimmerman TP; Novokhatny VV
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):241-6. PubMed ID: 17413760
[TBL] [Abstract][Full Text] [Related]
13. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
Lebreton de Vonne T; Mouray H
Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
[No Abstract] [Full Text] [Related]
14. New neonatal problems of blood coagulation and fibrinolysis. I. The change of plasmin inhibitor levels in the newborn infant.
Suzuki S; Wake N; Yoshiaki K
J Perinat Med; 1976; 4(4):213-20. PubMed ID: 64604
[TBL] [Abstract][Full Text] [Related]
15. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
[TBL] [Abstract][Full Text] [Related]
16. The alpha2-plasmin inhibitor levels in liver diseases.
Aoki N; Yamanaka T
Clin Chim Acta; 1978 Mar; 84(1-2):99-105. PubMed ID: 76519
[TBL] [Abstract][Full Text] [Related]
17. Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs.
Aasen AO; Gallimore MJ; Ohlsson K; Amundsen E
Haemostasis; 1978; 7(2-3):164-9. PubMed ID: 77807
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
Kolev K; Léránt I; Tenekejiev K; Machovich R
J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
[TBL] [Abstract][Full Text] [Related]
19. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
Harpel PC
J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: The contribution of individual protease inhibitors to plasma antiplasmin activity.
Crawford GP; Ogston D; Douglas AS
Thromb Diath Haemorrh; 1975 Sep; 34(1):319. PubMed ID: 52898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
